Pengfei Shen

机构：Hebei Medical University, Jiangsu University, Third Hospital of Hebei Medical University · ORCID：0000-0002-6132-6384

发表论文 40 篇 · 总被引 178 次 · h-index 7

代表论文

• The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis (2024 · Cancer Treatment Reviews · 被引 26)
• Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents (2024 · Cancer Biology and Medicine · 被引 19)
• Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma (2024 · Molecular Cancer · 被引 18)
• Magnetite-enhanced chain elongation via endogenous electron donors through a novel fungi-bacteria microbiome (2025 · Water Research · 被引 11)
• Sintilimab Plus Axitinib for Advanced Fumarate Hydratase–Deficient Renal Cell Carcinoma (2025 · JAMA Oncology · 被引 6)
• A Study of the Effects of Moisture on Composite−to−Metal Double−Lap Shear Joints (2024 · Materials · 被引 6)